Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of Esaxerenone add-on therapy in hypertensive patients and its correlation with urinary Na/K ratio or salt intake
jRCTs031210273Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of esaxerenone in essential hypertension, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Change from baseline in early morning home blood pressure. Started Oct 2021; status: completed.
02
Drugs
esaxerenone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on jRCTs031210273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210273.